|
USO1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.676900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.278200E-02 |
| Normal-vs-Stage2 |
1.672650E-01 |
| Normal-vs-Stage3 |
1.96502999999515E-05 |
| Normal-vs-Stage4 |
2.976400E-03 |
| Stage1-vs-Stage2 |
9.000200E-01 |
| Stage1-vs-Stage3 |
2.455200E-03 |
| Stage1-vs-Stage4 |
1.759960E-01 |
| Stage2-vs-Stage3 |
5.818300E-02 |
| Stage2-vs-Stage4 |
2.483600E-01 |
| Stage3-vs-Stage4 |
4.625400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.582100E-04 |
| Normal-vs-AfricanAmerican |
6.681600E-01 |
| Normal-vs-Asian |
8.955900E-03 |
| Caucasian-vs-AfricanAmerican |
5.029600E-02 |
| Caucasian-vs-Asian |
6.777800E-01 |
| AfricanAmerican-vs-Asian |
1.274590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.355800E-03 |
| Normal-vs-Female |
3.356200E-03 |
| Male-vs-Female |
5.740400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.325800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.413600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.316330E-03 |
| Normal-vs-Age(81-100Yrs) |
2.184000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.002200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.852300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.388800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.411000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.743800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.374000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.784880E-03 |
| Classical-VS-Follicular |
1.959570E-02 |
| Classical-VS-Other |
3.215000E-01 |
| Classical-VS-Normal |
4.777300E-03 |
| Tall-VS-Follicular |
4.04139999999886E-05 |
| Tall-VS-Other |
7.667600E-01 |
| Tall-VS-Normal |
3.7273999999865E-06 |
| Follicular-VS-Other |
2.656200E-02 |
| Follicular-VS-Normal |
8.220600E-01 |
| Other-VS-Normal |
1.966020E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.357750E-02 |
| Normal-vs-N1 |
5.70189999999915E-05 |
| N0-vs-N1 |
1.918420E-02 |
|
|
